Business
RENX to present at 39th JP Morgan Healthcare Conf.
RENX to present at 39th JP Morgan Healthcare Conf..
About this update from Renalytix Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 3438K\n Renalytix AI PLC\n 04 January 2021\n \n \n \n \n \n \n \n Renalytix AI plc\n \n \n (\"RenalytixAI\" or the \"Company\")\n \n \n \n \n \n RenalytixAI to Present at the 39th Annual J.P. Morgan Healthcare Conference \n \n \n \n \n \n \n NEW YORK, 4 January 2021 \n \n - Renalytix AI plc \n (LSE\n : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today \n announced the Company will be presenting at the upcoming 39th Annual J.P. Morgan Virtual Healthcare Conference. \n \n \n \n \n \n RenalytixAI's management is scheduled to present on Wednesday, January 13 at 10:00 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the \"Investors\" section of the company website at \n \n \n investors.renalytixai.com\n \n \n .\n \n \n \n \n \n \n \n \n For further information, please contact:\n \n \n \n \n \n \n \n \n \n Renalytix AI plc \n \n \n \n \n \n \n www.renalytixai.com\n \n \n \n \n \n \n \n \n James McCullough, CEO \n \n \n \n \n Via Walbrook PR \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Stifel (Nominated Adviser, \n \n \n Joint Broker\n \n \n )\n \n \n \n \n \n Tel: 020 7710 7600\n \n \n \n \n \n \n Alex Price / \n Nicholas Moore\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Investec Bank plc (Joint Broker)\n \n \n \n \n Tel: 020 7597 4000\n \n \n \n \n \n \n Gary Clarence / Daniel Adams\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Walbrook PR Limited\n \n \n \n \n \n Tel: 020 7933 8780 \n \n or \n \n \n [email protected]\n \n \n \n \n \n \n \n \n Paul McManus / Lianne Cawthorne\n \n \n \n \n Mob: 07980 541 893 / 07584 391 303\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About RenalytixAI\n \n \n RenalytixAI is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI's products are being designed to make significant improvements in kidney disease diagnosis, transplant management, clinical care, patient strati...